Vallon Pharmaceuticals is a Philadelphia-based company specializing in the development of innovative treatments for stimulant abuse, ADHD, and narcolepsy. With a strong leadership team and scientific advisory board, the company is dedicated to advancing its pipeline of novel therapies through rigorous clinical data and publications.
Utilizing cutting-edge technology and a deep understanding of the mechanism of action, Vallon Pharmaceuticals aims to provide effective solutions for patients suffering from these conditions, while also collaborating with key stakeholders in the field. With a focus on patient resources and a commitment to transparency, the company strives to make a positive impact in the pharmaceutical industry.
Generated from the website